Pricing Log in Create free account

Moolec Science SA (MLEC) vs Valion Bio, Inc. (VBIO)

Moolec Science SA and Valion Bio, Inc. are both Biotechnology companies. Valion Bio, Inc. is the larger, with a market value of $1.1M against $620.0K — 1.7× the size. Valion Bio, Inc. has the higher net margin (0.00% vs −105.7%) and the lower return on invested capital (−61.0% vs 0.00%). Across the 15 metrics below, Moolec Science SA leads on 11 and Valion Bio, Inc. on 4.

Valuation

Metric MLEC VBIO Biotechnology median
P/E n/m n/m 10.60
P/S 0.03 0.14 9.40
P/B 0.01 0.02 2.13
Price to free cash flow 0.01 n/m 25.18
EV/EBITDA 1.76 n/m 0.66
EV/Sales 8.37 11.09 9.02
Earnings yield (3,822.12%) (40,026.00%) (32.88%)
Free cash flow yield 8,301.70% (22,510.36%) (23.13%)

Profitability

Metric MLEC VBIO Biotechnology median
Gross margin 2,373.25% (58.09%) 68.51%
Operating margin 244.93% 0.00% 0.00%
Net margin (105.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (489.30%) (51.96%)
Return on assets 0.00% (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric MLEC VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) (793.17%) 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC VBIO Biotechnology median
Debt to equity 4.37 0.62 0.00
Current ratio 0.15 1.11 4.97
Net debt to EBITDA (2.73) 0.79 1.01

Dividend

Metric MLEC VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MLEC VBIO Biotechnology median
Market cap 620.00k 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack